COPD epidemiology

Amegadzie, J. E., Gao, Z., Quint, J. K., Russell, R., Hurst, J. R., . Y. Lee, T., et al. (2023). QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax. http://doi.org/10.1136/thorax-2023-220615

View

Whittaker, H., Rothnie, K. J., & Quint, J. K. (2023). Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax. http://doi.org/10.1136/thorax-2022-219320

View

Lenoir, A., Whittaker, H., Gayle, A., Jarvis, D., & Quint, J. K. (2022). Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data. Thorax. http://doi.org/10.1136/thorax-2022-218724

View

Whittaker, H., Nordon, C., Rubino, A., Morris, T., Xu, Y., de Nigris, E., et al. (2022). Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax. http://doi.org/10.1136/thorax-2022-219039

View

Czira, A., Banks, V., Requena, G., Wood, R., Tritton, T., Wild, R., et al. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243

View

Whittaker, H., Van Ganse, E., Dalon, F., Nolin, M., Marrant-Micallef, C., Pison, C., et al. (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2021-001150

View